HomeHighligthsPublications

Publications

This QDIPCinfo replaces the QDIPCinfo Terms of Application – Group Size published in June 2019

Check out the new 2020 terms or download the document.

The Quebec Drug Insurance Pooling Corporation (QDIPC) is the only body recognized in Quebec to pool the portion of drug insurance risks that are above its established thresholds. Under the Act, Pooling is mandatory in Quebec and applies before any other form of reinsurance

The primary objective of risk pooling is to ensure accessibility to insurance coverage, despite the risk of high costs of certain drugs.

The primary objective of risk pooling is to ensure accessibility to insurance coverage, despite the risk of high costs of certain drugs. The process keeps the risks within the industry and

Check out the new 2019 terms or download the document.

The System’s Foundation - Its Origins. The Quebec Drug Insurance Pooling Corporation (QDIPC) was created following the adoption of the Prescription Drug Insurance Act (the Act) on June 19, 1996, and the establishment of the basic prescription drug insurance plan, which has been in effect since January 1, 1997.

Check out the new 2018 terms or download the document.

The year 2017 marks the 20th anniversary of the Quebec Drug Insurance Pooling Corporation. Over the past two decades, the Corporation has worked tirelessly to ensure the smooth functioning of the risk pooling system set up by the life and health insurance industry.

The Corporation reaffirms its commitment to maintaining the pooling system.

The year 2017 marks the 20th anniversary of the Quebec Drug Insurance Pooling Corporation. Over the past two decades, the Corporation has worked tirelessly to ensure the smooth functioning of the risk pooling system set up by the life and health insurance industry.

The increasing cost of drugs is a constant concern for the Corporation, which ensures that the pooling system continues to protect the viability of plans in case of major claims.

The Corporation recommends that insurers and third party administrators of employee benefit plans inform their customers about pooling arrangements, particularly the annual factor included in the insurance premium or added to the fee (depending on whether it is an insured or non-insured plan).

In sections 15.1, 42.1 and 42.2 The Drug Insurance Act gives the definition of a group of persons eligible for private coverage of pharmaceutical services and medications and the conditions for applying such coverage.

The terms and conditions of the pooling and compensation system are based largely on the size of the groups presented for pooling. The size is therefore a key piece of information for the Corporation.

Since the adoption in 2012 of the Participant Audit Policy, 13 of 32 participants have been audited. Four other audits will take place during the summer of 2016.